SANGAMO THERAPEUTICS, INC (SGMO) Operating Lease, Right-of-Use Asset USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sangamo Therapeutics, Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2018 to 2024.
  • Sangamo Therapeutics, Inc Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $20.9 M, a 57% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $20.9 M -$27.8 M -57% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $26 M -$36 M -58.1% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 $27.2 M -$37.7 M -58.1% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $46.8 M -$21.9 M -31.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $48.7 M -$22.2 M -31.3% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $62 M -$11.2 M -15.3% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $65 M -$1.27 M -1.92% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $68.7 M +$393 K +0.58% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $70.9 M +$575 K +0.82% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $73.2 M +$2.14 M +3.01% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $66.2 M -$5.41 M -7.55% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $68.3 M -$5.2 M -7.07% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $70.3 M -$5.05 M -6.7% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $71 M -$6.24 M -8.08% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $71.6 M -$5.87 M -7.57% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $73.5 M -$5.93 M -7.47% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $75.4 M +$47.2 M +167% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $77.3 M +$77.3 M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $77.5 M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $79.4 M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $28.2 M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.